Cargando…
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
HOXA4 is a novel oncogene that has been observed in many kinds of tumors, but its role during glioma carcinogenesis and its clinical significance in diagnosing and prognosis human glioma remains unknown. In the present study, the Chinese Glioma Atlas (CGGA)-RNA sequencing database, CGGA microarray,...
Autores principales: | Yu, Zhenghong, Liu, Zhendong, Lian, Xiaoyu, Cheng, Xingbo, Liu, Binfeng, Zhang, Bo, Wang, Hongbo, Wang, Jialin, Li, Ang, Ren, Zhishuai, Pang, Bo, Qian, Rongjun, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645261/ https://www.ncbi.nlm.nih.gov/pubmed/35852388 http://dx.doi.org/10.1080/15384101.2022.2096715 |
Ejemplares similares
-
Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021) -
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022) -
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021) -
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)